After a tumultuous two-day meeting marked by confusion and missteps, an advisory committee endorsed guidelines that would ...

Members of ACIP voted to table a planned vote on withholding some infants’ first hepatitis B vaccine dose, adding more ...

The purchase gives Biogen full access to an implantable device that could help patients avoid the repeat lumbar punctures ...

The British drugmaker’s commitment comes as some of its pharma peers question their U.K. presence amid a widening row there ...

Unified data also improves AI outputs. For example, by drawing up-to-date information from a variety of an organization’s ...

A deal with Dutch startup VarmX gives CSL an option to buy a Phase 3-ready drug that could reverse the effects of popular ...

Susan Monarez told Senators at a hearing Wednesday that Robert F. Kennedy Jr. pushed her out for refusing to rubber-stamp ...

A drug licensed from Pfizer will be submitted to the FDA next year after study results showed it reduced dermatomyositis ...

T.Rx Capital was co-founded by Michael Langer, former Pear Therapeutics CEO Corey McMann and Eli Lilly veteran Kwesi Frimpong ...

One analysts called the Phase 2 study results a “best-case scenario” for a drug Rapport is developing to treat focal onset ...

Modern obesity trials are inherently complex, but the momentum behind these therapeutics has never been greater. With over ...

The committee reconvened Friday to re-do a vote on coverage of the combined MMRV shot through the Vaccines for Children ...